Sort by:
ordered by relevance and dateWhite Paper Examines the Importance of On-Dose Technologies in the Fight Against Illegal Diversion of Opioid Medications (Marketwire)
Whitepaper | finance.yahoo.com | May 6, 2009
SKOKIE, IL--(MARKET WIRE)--May 6, 2009 -- NanoGuardian(TM), a division of NanoInk® that delivers brand protection solutions to fight illegal diversion and counterfeiting, announced today that
http://finance.yahoo.com/news/White-Paper-Examines-the-iw-15152712.html
NKI-AVL :: Borst
DNA base J This project is an offshoot of our long-standing interest in the mechanisms of antigenic variation in African trypanosomes. b-glucosyl-hydroxymethyluracil (base J), which we discovered in 1993 (Gommers-Ampt et al.
http://www.nki.nl/Research/Faculty+and+Research/Divisions/Molecular+Biology/Borst.htm
RIVERSIDE TRANSITIONAL CARE
Resource | healthcare.zibb.com
Riverside Transitional Care® is a registered trademark used for Adult Daycare Services Medical Services, Namely, Infusion Services, Namely, the Delivery of Intravenous (Iv) Medications and Fluids, Blood and Blood Products and owned by Christiana Care Health System, Inc..
http://healthcare.zibb.com/trademark/riverside+transitional+care/30902032
BIA Publishes White Paper: ISO 9000 Role in Document Review, Emphasizes 'Quality Equals Defensibility'
Whitepaper | www.bio-medicine.org | Oct 2, 2009
...NEW YORK Oct. 2 /- Business Intelligence Associat...BIA's white paper identifies difficulties and solutions in developing ... BIA's Document Review Services are independent of any single review t...Feinberg adds BIA spent over a year ensuring that there is a
Research
The team at the Johns Hopkins Facial Paralysis & Pain Treatment Center is committed to conducting cutting-edge research to evaluate and improve current treatments for facial paralysis and pain, as well as developing innovative therapies. Research publications are listed by physician name.
http://www.hopkinsmedicine.org/facial_paralysis_pain_treatment_center/research/
KEEPMEHOME
Resource | hospitality.zibb.com
Keepmehome Keepmehome® is a registered trademark used for Cleaning of Residences of Clients Who Are Being Providing Home Care Preparation of, or Supplying, Meals To Clients At Their Residences Home Health Care Services, Interactive Medical Monitoring and Alert Service For Reminding Clients of
INCB9471 - CCR5 Antagonist for Treatment of HIV Infection
Resource | www.drugdevelopment-technology.com | Jan 23, 2008
Under development by Incyte Corporation, INCB9471 is an experimental small molecule drug indicated for the treatment of infection due to the human immunodeficiency virus (HIV). It is a member of a new class of oral HIV drugs called CCR5 receptor antagonists or inhibitors.
http://www.drugdevelopment-technology.com/projects/incb9471/
Psychologists Therapist and Counselors - The online home for mental health professionals
If you even suspect that your client is either the victim of family abuse or is an abuser, you have an ethical duty to protect victims and, depending on local laws, may have a legal duty to report the situation.
http://www.4therapy.com/professional/about_us/item.php?uniqueid=4613&categoryid=272&
White Papers/Case Studies
Whitepaper | www.dddmag.com
Drug researchers use white papers and case studies to justify implementing new solutions. Gain additional exposure for your research papers while generating quality leads for sales purposes.
Pfizer, Newcon Containment Facility,
Resource | www.pharmaceutical-technology.com | Apr 30, 2008
News and project information on the Pfizer, Newcon Containment Facility, Illertissen
http://www.pharmaceutical-technology.com/projects/pfizerdeutschland/
